NM_001128227.3:c.1374+44G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001128227.3(GNE):​c.1374+44G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00725 in 1,230,326 control chromosomes in the GnomAD database, including 374 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 201 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 173 hom. )

Consequence

GNE
NM_001128227.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.143

Publications

1 publications found
Variant links:
Genes affected
GNE (HGNC:23657): (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
CLTA (HGNC:2090): (clathrin light chain A) Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 9-36227204-C-T is Benign according to our data. Variant chr9-36227204-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0913 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNENM_001128227.3 linkc.1374+44G>A intron_variant Intron 7 of 11 ENST00000396594.8 NP_001121699.1
GNENM_005476.7 linkc.1281+44G>A intron_variant Intron 7 of 11 ENST00000642385.2 NP_005467.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNEENST00000396594.8 linkc.1374+44G>A intron_variant Intron 7 of 11 1 NM_001128227.3 ENSP00000379839.3
GNEENST00000642385.2 linkc.1281+44G>A intron_variant Intron 7 of 11 NM_005476.7 ENSP00000494141.2

Frequencies

GnomAD3 genomes
AF:
0.0283
AC:
4308
AN:
152034
Hom.:
200
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0938
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00622
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.0244
GnomAD2 exomes
AF:
0.00871
AC:
2136
AN:
245300
AF XY:
0.00711
show subpopulations
Gnomad AFR exome
AF:
0.0953
Gnomad AMR exome
AF:
0.00820
Gnomad ASJ exome
AF:
0.00569
Gnomad EAS exome
AF:
0.0000553
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00114
Gnomad OTH exome
AF:
0.00651
GnomAD4 exome
AF:
0.00427
AC:
4606
AN:
1078174
Hom.:
173
Cov.:
15
AF XY:
0.00409
AC XY:
2265
AN XY:
553846
show subpopulations
African (AFR)
AF:
0.0982
AC:
2533
AN:
25782
American (AMR)
AF:
0.00839
AC:
369
AN:
43972
Ashkenazi Jewish (ASJ)
AF:
0.00594
AC:
140
AN:
23562
East Asian (EAS)
AF:
0.0000264
AC:
1
AN:
37902
South Asian (SAS)
AF:
0.00600
AC:
468
AN:
77978
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53068
Middle Eastern (MID)
AF:
0.0127
AC:
64
AN:
5046
European-Non Finnish (NFE)
AF:
0.000803
AC:
613
AN:
763146
Other (OTH)
AF:
0.00874
AC:
417
AN:
47718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
243
486
729
972
1215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0284
AC:
4316
AN:
152152
Hom.:
201
Cov.:
32
AF XY:
0.0275
AC XY:
2049
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0938
AC:
3891
AN:
41496
American (AMR)
AF:
0.0159
AC:
243
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00622
AC:
30
AN:
4820
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10578
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68000
Other (OTH)
AF:
0.0242
AC:
51
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
211
422
632
843
1054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0208
Hom.:
50
Bravo
AF:
0.0329
Asia WGS
AF:
0.00924
AC:
32
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.7
DANN
Benign
0.65
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16933102; hg19: chr9-36227201; COSMIC: COSV64953490; API